We are live on ! Find out more
EWA

Evolution Wealth Advisors Portfolio holdings

AUM $981M
1-Year Est. Return 21.2%
This Fund
S&P 500
This Quarter Est. Return
+18.67%
1 Year Est. Return
+21.2%
3 Year Est. Return
+66.36%
5 Year Est. Return
+44.78%
10 Year Est. Return
–
AUM
$443M
AUM Growth
+$77.7M
Cap. Flow
+$25.1M
Cap. Flow %
5.67%
Top 10 Hldgs %
47%
Holding
659
New
70
Increased
89
Reduced
169
Closed
84

Top Buys

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$12.2M
2
VB icon
Vanguard Small-Cap ETF
VB
+$11.1M
3
SQM icon
Sociedad Química y Minera de Chile
SQM
+$9.33M
4
ARKF icon
ARK Blockchain & Fintech Innovation ETF
ARKF
+$9.22M
5
AAXJ icon
iShares MSCI All Country Asia ex Japan ETF
AAXJ
+$8.21M

Top Sells

Rank Stock Value
1
ITA icon
iShares US Aerospace & Defense ETF
ITA
+$9.4M
2
EWU icon
iShares MSCI United Kingdom ETF
EWU
+$7.12M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$4.73M
4
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$4.65M
5
IVE icon
iShares S&P 500 Value ETF
IVE
+$3.81M

Sector Composition

Rank Sector Weight
1 Materials 14.85%
2 Consumer Discretionary 5.22%
3 Technology 2.7%
4 Communication Services 2.04%
5 Healthcare 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTI icon
251
British American Tobacco
BTI
$128B
$22K 0.01%
+600
New +$21.5K
GILD icon
252
Gilead Sciences
GILD
$162B
$22K 0.01%
386
-300
-44% -$18.1K
GMED icon
253
Globus Medical
GMED
$10.2B
$22K 0.01%
334
– –
INSM icon
254
Insmed
INSM
$23.2B
$22K 0.01%
650
-312
-32% -$11.4K
ORCL icon
255
Oracle
ORCL
$345B
$22K 0.01%
346
– –
RPRX icon
256
Royalty Pharma
RPRX
$26.2B
$22K 0.01%
447
+64
+17% +$2.71K
RYTM icon
257
Rhythm Pharmaceuticals
RYTM
$7.06B
$22K 0.01%
737
-95
-11% -$2.41K
SPHD icon
258
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.31B
$22K 0.01%
575
– –
BBVA icon
259
Banco Bilbao Vizcaya Argentaria
BBVA
$140B
$21K ﹤0.01%
4,282
– –
FOLD
260
DELISTED
Amicus Therapeutics
FOLD
$21K ﹤0.01%
930
-821
-47% -$16.8K
ICUI icon
261
ICU Medical
ICUI
$3.83B
$21K ﹤0.01%
97
– –
AMGN icon
262
Amgen
AMGN
$199B
$20K ﹤0.01%
87
– –
AMTB icon
263
Amerant Bancorp
AMTB
$1B
$20K ﹤0.01%
1,319
– –
DXCM icon
264
DexCom
DXCM
$27.3B
$20K ﹤0.01%
216
+92
+74% +$8.21K
HIG icon
265
Hartford Financial Services
HIG
$38.9B
$20K ﹤0.01%
400
– –
LIN icon
266
Linde
LIN
$233B
$20K ﹤0.01%
76
– –
PGR icon
267
Progressive
PGR
$120B
$20K ﹤0.01%
201
– –
SAGE
268
DELISTED
Sage Therapeutics
SAGE
$20K ﹤0.01%
228
-90
-28% -$6.63K
USMV icon
269
iShares MSCI USA Min Vol Factor ETF
USMV
$23B
$20K ﹤0.01%
300
– –
MRTX
270
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$20K ﹤0.01%
92
-87
-49% -$18.8K
CHTR icon
271
Charter Communications
CHTR
$15.5B
$19K ﹤0.01%
28
-186
-87% -$118K
EL icon
272
Estee Lauder
EL
$28.6B
$19K ﹤0.01%
70
-1
-1% -$241
FATE icon
273
Fate Therapeutics
FATE
$291M
$19K ﹤0.01%
+205
New +$12.7K
TAK icon
274
Takeda Pharmaceutical
TAK
$53.6B
$19K ﹤0.01%
1,057
-324
-23% -$5.68K
TFX icon
275
Teleflex
TFX
$5.81B
$19K ﹤0.01%
47
+40
+571% +$14.8K
9 10
11
12 13

Similar funds

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
BIP
Blueprint Investment Partners Greensboro, North Carolina $980M AUM 27.19% 1-Year Est. Return
RA
Rational Advisors Huntington, New York $980M AUM 9.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $977M AUM 19.09% 1-Year Est. Return
FCM
Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return
PE
PSG Equity Boston, Massachusetts $977M AUM 13.39% 1-Year Est. Return

Evolution Wealth Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Evolution Wealth Advisors held 659 positions worth $443M, up 21% from $366M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Evolution Wealth Advisors deployed $25.1M of net new capital in Q4 2020, opening 70 new positions and adding to 89 existing holdings. Its largest new stake was ARK Innovation ETF: 112,558 shares worth $14M.

By sector, the portfolio is most concentrated in Materials at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares US Aerospace & Defense ETF, an estimated $9.4M trimmed.

  • Evolution Wealth Advisors's largest Q4 2020 buy was ARK Innovation ETF: 112,558 shares worth $14M.
  • Evolution Wealth Advisors added most to Vanguard Small-Cap ETF in Q4 2020, an estimated $11.1M increase.
  • Evolution Wealth Advisors's biggest Q4 2020 reduction was iShares US Aerospace & Defense ETF, cutting an estimated $9.4M.
  • Evolution Wealth Advisors fully exited iShares MSCI United Kingdom ETF in Q4 2020, selling an estimated $7.12M.
  • Evolution Wealth Advisors's ten largest holdings make up 47% of its $443M portfolio in Q4 2020.
  • Evolution Wealth Advisors opened 70 new positions and closed 84 in Q4 2020.
  • Evolution Wealth Advisors's portfolio value rose 21% quarter-over-quarter to $443M.

Based on Evolution Wealth Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.